Healthcare
Deal focus: HaloDoc targets healthcare access
A spin-out from domestic pharmaceutical players Mensa Group, Indonesian healthcare services app HaloDoc wants to make medication and doctor consultations more accessible to the masses
Indonesia healthcare services app gets $11m Series A
Clermont Group, a Singapore-based private investment firm led by billionaire Richard Chandler, has led a Series A round worth $11 million for Indonesian healthcare services app HaloDoc.
Japan's Taiho Ventures backs US cancer drug developer
Taiho Ventures, the newly established VC arm of Japan’s Taiho Pharmaceutical, has participated in a $70 million Series B round of funding for Arcus Biosciences, a US-based start-up that develops cancer drugs.
Premji invests in India's Lenskart
PremjiInvest, the family office of Wipro Group chairman Azim Premji, has invested in Indian online eyewear retailer Lenskart.
Singapore's Venturecraft launches $37m tech fund
Venturecraft, a Singapore-based VC investor and accelerator, has launched a new S$50 million ($37 million) investment fund aimed at early and growth stage medical technology (medtech) and internet start-ups in Asia.
Deal focus: Mr Vitamins gets deal-by-deal treatment
Executives from Ironbridge Capital and Catalyst Investment Managers team up with retail veteran Brett Blundy to take Australia's Mr Vitamins into its next stage of growth
VC-backed Berry Genomics to list in Shenzhen via reverse merger
Berry Genomics, a Chinese genetic test developer backed by Qiming Venture Partners and Legend Capital, is looking to list in Shenzhen through a reverse merger.
Apis, ICICI invest in India's Star Health
Apis Partners and ICICI Venture have invested in Indian health insurance provider Star Health & Allied Insurance.
China cloud radiotherapy start-up Allcure raises $27m
Beijing Allcure Medical Technology, a Chinese medical start-up that develops cloud-based radiotherapy technology, has raised an extended Series A round of funding worth RMB180 million ($27 million).
Sequoia leads $27m round for India, US-based Mitra
Sequoia India and US-based Sands Capital Ventures have led a $27.4 million Series B round of funding for Mitra Biotech, an India and US-based company that focuses on personalized cancer therapies.
CVC agrees $166m deal to invest in Indonesian hospital operator
CVC Capital Partners has once again entered into a partnership with Indonesia’s Lippo Group, agreeing a IDR2.2 trillion ($165.7 million) deal to invest in Siloam International Hospitals, which is controlled by the Riady family-owned business.
China's I-Bridge Capital launches Israel pharma JV
Chinese healthcare-focused VC firm I-Bridge Capital has launched a joint venture (JV) with Israeli biopharmaceutical company BioLineRx that will target cross-border penetration of Chinese markets.
Quadrant buys Australian occupational health specialist
Quadrant Private Equity has acquired a majority stake in Injury Treatment, an Australia-based provider of injury prevention and rehabilitation services to employers and insurers, for an undisclosed sum.
China's KingYee, Quyiyuan raise combined $47m
Chinese mobile healthcare services provider Shanghai KingYee and its independent unit Quyiyuan - which operates a medical services booking app - have raised a combined RMB313 million ($47 million) in their latest rounds of funding.
IFC, SeaLink invest $15m in Indian clinic chain
SeaLink Capital Partners and the International Finance Corporation have committed a INR 1 billion ($14.9 million) Series C round to India-based dialysis clinic chain NephroPlus.
India's PE-backed Laurus Labs file for IPO
Indian pharmaceutical products developer Laurus Labs has filed for a domestic IPO, offering a partial exit for backers Warburg Pincus and Eight Roads Ventures.
India biopharma player Vyome gets $14m Series C
Indian biopharmaceutical company Vyome Biosciences has raised a $14 million Series C funding round led by US investors Perceptive Advisors and Romulus Capital.
Australia's Atomo gets $3.5m from Bill Gates-backed fund
A US-based healthcare fund backed by Microsoft founder Bill Gates has led a A$4.5 million ($3.5 million) investment round in Australian medical technology company Atomo Diagnostics.
India's WestBridge leads round for healthcare big data start-up
WestBridge Capital Partners has led a $15.6 million Series A round of funding for Innovaccer, a healthcare-focused IT outsourcing start-up with bases in Palo Alto and New Delhi.
Golden Gate invests $2.5m in Indonesia's Alodokter
Singapore’s Golden Gate Ventures has committed $2.5 million to a Series A funding round for Indonesian healthcare information portal operator Alodokter.
Australian government launches $191m biomedical VC fund
The Australian government has seeded $250 million ($191 million) from its Medical Research Future Fund (MRFF) to a biomedical technology-focused venture investment vehicle. It will match private sector commitments, bringing the total available for deployment...
PICC leads $64m round for China's Neusoft Xikang
PICC Property and Casualty, a subsidiary of People's Insurance Company of China (PICC), has led a $64 million funding round for cloud-based medical and healthcare services provider Neusoft Xikang.
Primavera, Shanghai Pharma to buy Australia's Vitaco
Primavera Capital and Shanghai Pharmaceuticals have agreed to buy Australia-listed nutrition and healthcare products company Vitaco for approximately A$313 million ($238 million).
MPM Capital forms VC fund with Japan's Astellas Pharma
MPM Capital, a US venture firm focused on early-stage life science companies, has launched a new investment vehicle in partnership with Japanese pharmaceutical company Astellas Pharma.